Find clinical trials for Multiple Sclerosis (MS) in Durham, NC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Sclerosis (MS) trials near Durham, NC, USA:
of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized...
Phase 3
Durham, North Carolina, United States and 18 other locations
with Parkinson's disease (PD), essential tremor (ET), dystonia or multiple sclerosis (MS). These data will guide the desig...
Durham, North Carolina, United States and 2 other locations
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...
Phase 3
Durham, North Carolina, United States and 107 other locations
This study will evaluate the safety, tolerability, and descriptive efficacy of BIIB017 in pediatric participants with relapsing-remitting multiple...
Phase 3
Chapel Hill, North Carolina, United States and 65 other locations
and adolescents 10 to 17 years of age with relapsing forms of multiple sclerosis (MS).Secondary Objective:To assess the ef...
Phase 3
Raleigh, North Carolina, United States and 54 other locations
This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofat...
Phase 4
Chapel Hill, North Carolina, United States and 32 other locations
This study will evaluate the impact of ofatumumab in Relapsing Remitting Multiple Sclerosis (RRMS) participants that are very early...
Phase 4
Raleigh, North Carolina, United States and 35 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Raleigh, North Carolina, United States and 208 other locations
for the overall conduct of the study at the site, confirmation of subject eligibility, routine study subject clinical management including for MS...
Phase 3
Chapel Hill, North Carolina, United States and 60 other locations
This is a randomized, double-blind study of PIPE-307 or placebo in subjects with relapsing-remitting multiple sclerosis. Subjects w...
Phase 2
Raleigh, North Carolina, United States and 24 other locations
Clinical trials
Research sites
Resources
Legal